Documents
The impact of the COVID-19 response on the supply chain, availability and cost of generic antiretroviral medicines for HIV in low- and middle-income countries
22 June 2020
The objective of this report is to assess the situational landscape during mid-May 2020 surrounding the value chain of the production and distribution of generic antiretroviral medicines in low- and-middle-income countries and to provide recommendations on mitigating the risks of potential disruptions.
Related
Cambodia showcases huge progress towards ending AIDS, announces a financial contribution to UNAIDS

16 May 2025
What the data tell us: Projections for the HIV epidemic in western and central Europe and North America in 2030
28 March 2025